Literature DB >> 19096027

Fate of culture-expanded mesenchymal stem cells in the microvasculature: in vivo observations of cell kinetics.

Catalin Toma1, William R Wagner, Shivani Bowry, Abigail Schwartz, Flordeliza Villanueva.   

Abstract

Vascular delivery of mesenchymal stem cells (MSCs) following myocardial infarction is under clinical investigation. Little is known about the microvascular fate of MSCs. We used intravital microscopy of rat cremaster muscle microcirculation to track intraarterially delivered MSCs. Rat MSCs (average diameter, 23 microm) were bolused into the ipsilateral common iliac artery. Interrogation of an arteriole-venule pair revealed that 92+/-7% (n=6) of MSCs arrest and interrupt flow during first pass at the precapillary level, resulting in decreased flow in the feeding arteriole (velocity decreased from 6.3+/-1.0 to 4.6+/-1.3 mm/sec; P<0.001). MSC deformability evaluated using filtration through polycarbonate membranes revealed that the cortical tension of MSCs (0.49+/-0.07 dyne/cm, n=9) was not different from that of circulating mononuclear cells (0.50+/-0.05 dyne/cm, n=7). When intravital microscopy was performed 3 days following injection, the number of MSCs in the cremaster further decreased to 14% of the initial number, because of cell death in situ. In vivo labeling of the basement membrane revealed that at 1 day, the surviving cells were spread out on the luminal side of the microvessel, whereas at 3 days, they integrated in the microvascular wall. Despite their deformability, intraarterially delivered MSCs entrap at the precapillary level because of their large size, with a small proportion of surviving MSCs integrating in a perivascular niche.

Entities:  

Mesh:

Year:  2008        PMID: 19096027      PMCID: PMC3700384          DOI: 10.1161/CIRCRESAHA.108.187724

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  25 in total

1.  Molecular and cellular characterisation of highly purified stromal stem cells derived from human bone marrow.

Authors:  Stan Gronthos; Andrew C W Zannettino; Shelley J Hay; Songtao Shi; Stephen E Graves; Angela Kortesidis; Paul J Simmons
Journal:  J Cell Sci       Date:  2003-05-01       Impact factor: 5.285

2.  The mean filtration pressure of leukocyte suspensions and its relation to the passage of leukocytes through nuclepore filters and capillary networks.

Authors:  M J Eppihimer; H H Lipowsky
Journal:  Microcirculation       Date:  1994-12       Impact factor: 2.628

3.  An open cremaster muscle preparation for the study of blood vessels by in vivo microscopy.

Authors:  S Baez
Journal:  Microvasc Res       Date:  1973-05       Impact factor: 3.514

4.  Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart.

Authors:  Catalin Toma; Mark F Pittenger; Kevin S Cahill; Barry J Byrne; Paul D Kessler
Journal:  Circulation       Date:  2002-01-01       Impact factor: 29.690

5.  The dynamic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion.

Authors:  J Gao; J E Dennis; R F Muzic; M Lundberg; A I Caplan
Journal:  Cells Tissues Organs       Date:  2001       Impact factor: 2.481

6.  Effects of unfractionated heparin, low molecular weight heparin and r-hirudin on leukocyte adhesion in ischemia/reperfusion.

Authors:  Helmut Habazettl; Jens Lindert; Simonida Baeter; Konrad Neumann; Hermann Kuppe; Wolfgang M Kuebler; Axel R Pries; Andreas Koster
Journal:  Blood Coagul Fibrinolysis       Date:  2004-07       Impact factor: 1.276

7.  Intra-coronary arterial injection of mesenchymal stromal cells and microinfarction in dogs.

Authors:  P Richard Vulliet; Melanie Greeley; S Mitchell Halloran; Kristin A MacDonald; Mark D Kittleson
Journal:  Lancet       Date:  2004-03-06       Impact factor: 79.321

8.  Characterization of key mechanisms in transmigration and invasion of mesenchymal stem cells.

Authors:  Caroline Steingen; Florian Brenig; Laura Baumgartner; Joachim Schmidt; Annette Schmidt; Wilhelm Bloch
Journal:  J Mol Cell Cardiol       Date:  2008-03-19       Impact factor: 5.000

9.  Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction.

Authors:  Shao-liang Chen; Wu-wang Fang; Fei Ye; Yu-Hao Liu; Jun Qian; Shou-jie Shan; Jun-jie Zhang; Robert Zhao Chunhua; Lian-ming Liao; Song Lin; Jing-ping Sun
Journal:  Am J Cardiol       Date:  2004-07-01       Impact factor: 2.778

10.  Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: feasibility, cell migration, and body distribution.

Authors:  Israel M Barbash; Pierre Chouraqui; Jack Baron; Micha S Feinberg; Sharon Etzion; Ariel Tessone; Liron Miller; Esther Guetta; Dov Zipori; Laurence H Kedes; Robert A Kloner; Jonathan Leor
Journal:  Circulation       Date:  2003-08-04       Impact factor: 29.690

View more
  125 in total

Review 1.  Concise review: mesoangioblast and mesenchymal stem cell therapy for muscular dystrophy: progress, challenges, and future directions.

Authors:  Suzanne E Berry
Journal:  Stem Cells Transl Med       Date:  2014-11-12       Impact factor: 6.940

2.  Long-term engraftment of multipotent mesenchymal stromal cells that differentiate to form myogenic cells in dogs with Duchenne muscular dystrophy.

Authors:  Yuko Nitahara-Kasahara; Hiromi Hayashita-Kinoh; Sachiko Ohshima-Hosoyama; Hironori Okada; Michiko Wada-Maeda; Akinori Nakamura; Takashi Okada; Shin'ichi Takeda
Journal:  Mol Ther       Date:  2011-09-20       Impact factor: 11.454

3.  Magnetic enhancement of cell retention, engraftment, and functional benefit after intracoronary delivery of cardiac-derived stem cells in a rat model of ischemia/reperfusion.

Authors:  Ke Cheng; Konstantinos Malliaras; Tao-Sheng Li; Baiming Sun; Christiane Houde; Giselle Galang; Jeremy Smith; Noriko Matsushita; Eduardo Marbán
Journal:  Cell Transplant       Date:  2012-03-08       Impact factor: 4.064

Review 4.  Multipotent mesenchymal stromal cells and the innate immune system.

Authors:  Katarina Le Blanc; Dimitrios Mougiakakos
Journal:  Nat Rev Immunol       Date:  2012-04-25       Impact factor: 53.106

5.  Delayed recovery of myocardial blood flow after intracoronary stem cell administration.

Authors:  Mariann Gyöngyösi; Rayyan Hemetsberger; Susanne Wolbank; Valentin Pichler; Christoph Kaun; Aniko Posa; Zsolt Petrasi; Örs Petnehazy; Renate Hofer-Warbinek; Rainer de Martin; Florian Gruber; Imre Benedek; Teodora Benedek; Istvan Kovacs; Istvan Benedek; Christian A Plass; Silvia Charwat; Gerald Maurer
Journal:  Stem Cell Rev Rep       Date:  2011-09       Impact factor: 5.739

Review 6.  Stem cell-based therapies in ischemic heart diseases: a focus on aspects of microcirculation and inflammation.

Authors:  Junxi Wu; Jun Li; Nannan Zhang; Cuihua Zhang
Journal:  Basic Res Cardiol       Date:  2011-03-23       Impact factor: 17.165

7.  Mesenchymal stem cell therapy: Two steps forward, one step back.

Authors:  James Ankrum; Jeffrey M Karp
Journal:  Trends Mol Med       Date:  2010-03-23       Impact factor: 11.951

8.  Compaction, fusion, and functional activation of three-dimensional human mesenchymal stem cell aggregate.

Authors:  Ang-Chen Tsai; Yijun Liu; Xuegang Yuan; Teng Ma
Journal:  Tissue Eng Part A       Date:  2015-03-20       Impact factor: 3.845

9.  Phase I trial of repeated intrathecal autologous bone marrow-derived mesenchymal stromal cells in amyotrophic lateral sclerosis.

Authors:  Ki-Wook Oh; Chanil Moon; Hyun Young Kim; Sung-Il Oh; Jinseok Park; Jun Ho Lee; In Young Chang; Kyung Suk Kim; Seung Hyun Kim
Journal:  Stem Cells Transl Med       Date:  2015-05-01       Impact factor: 6.940

Review 10.  Molecular advances in reporter genes: the need to witness the function of stem cells in failing heart in vivo.

Authors:  Silvia Agostini; Fabio A Recchia; Vincenzo Lionetti
Journal:  Stem Cell Rev Rep       Date:  2012-06       Impact factor: 5.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.